NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED
NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED

Español

Logo of Nubeqa Highlights Real

Tony Romo and Bayer are kicking off the next chapter in the NUBEQA story

Tony Romo does not have prostate cancer and is not a NUBEQA patient. Ramiro is not a NUBEQA patient.

real-highlight-bg

Meaningful Moments

Tony teams up with his dad Ramiro, who has faced prostate cancer, to provide play-by-play commentary on videos shared by real NUBEQA patients and their families. The Romos know firsthand how important it is to be able to celebrate all of the everyday moments, both big and small. 

Let's check out the highlights!

Tony Romo does not have prostate cancer and is not a NUBEQA patient. Ramiro is not a NUBEQA patient.

Image with a text NUBEQA® RealTalk with Tony Romo

Hoping to bring more awareness to advanced prostate cancer, Tony is joined by an expert oncologist as well as a family facing the disease. These conversations aim to highlight the importance of staying informed about treatment options.

Rudi’s story

Rudi, a real patient taking NUBEQA, chats with Tony to discuss his experiences navigating advanced prostate cancer and how having the right game plan can make a difference.

Talk to your medical team today 
and see if NUBEQA is right for you.

Access the doctor discussion guide

Diana's story

Tony sits down with Diana, a caregiver of a loved one living with advanced prostate cancer to discuss the important role caregivers play in advocating for people living with this disease.

Caregivers: Your care means everything.
Access helpful resources that have been created just for you.

See caregiver tips

Tony & Dr. Barata talk about NUBEQA

Tony sits down with Dr. Pedro Barata, an oncologist, for a quick rundown on treatment with NUBEQA.

Looking for more information 
about this treatment?

Learn about NUBEQA
Alt tag

“It's all about being informed and advocating for your own needs by discussing treatment options with your doctors.”

-Tony Romo, former professional quarterback

Tony Romo does not have prostate cancer and is not a NUBEQA patient.

Tony Romo outdoors with a football in hand

Get connected by joining our mailing list for resources, tips, and more info on advanced prostate cancer

Sign up
Patient stories
Talking to

your doctor

Important Safety Information

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
  • have a history of seizures, brain injury, stroke, or brain tumors
  • have kidney or liver problems
  • are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
  • have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
  • are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

NUBEQA may cause serious side effects, including:

  • Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA.
  • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure during treatment with NUBEQA.

The most common side effects of NUBEQA include:

  • increase in liver function tests
  • decreased white blood cells (neutropenia)
  • feeling more tired than usual

The most common side effects of NUBEQA in combination with docetaxel include:

  • constipation
  • rash
  • decreased appetite
  • bleeding
  • weight gain
  • high blood pressure
  • decreased red blood cells (anemia)
  • high blood sugar levels
  • decreased white blood cells
  • increase in liver function tests
  • low blood calcium levels

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA.

Call your healthcare provider for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

Please see the full Prescribing Information.

WHAT IS NUBEQA<sup>&reg;</sup>?

NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

  • that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone
  • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone
  • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone in combination with docetaxel.

It is not known if NUBEQA is safe and effective in females or children.

© 2026 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

Date of last update: 1/20/2026